Furosemide Injection, Solution
Product Images NDC 25021-311

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 25021-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fur03 0001 01)

Chemical structure of Furosemide showing its molecular components, including a chlorobenzene ring with sulfonamide and carboxyl groups, and a furan ring attached via an amine linkage.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Fur03 0001 02)

Label for Furosemide Injection, USP 20 mg per 2 mL (10 mg per mL) solution for injection. Intended for intravenous or intramuscular use, preservative-free, in a 2 mL single-dose vial. Manufactured for Sagent Pharmaceuticals, Schaumburg, IL, made in India. Includes storage and usage warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.